The file's text, extracted by GovTribe without its formatting.
Special Notice Special Notice
| SUBJECT* |
| Supplies - Leica Immunohistochemistry Reagents/Kits/Consumables 5-Year IDIQ - Detroit |
GENERAL INFORMATION
| CONTRACTING OFFICE’S ZIP CODE* |
| 49037 |
| SOLICITATION NUMBER* |
| 36C25024Q0741 |
| RESPONSE DATE/TIME/ZONE |
| 07-31-2024 5:00 PM EASTERN TIME, NEW YORK, USA |
| ARCHIVE |
| 60 DAYS AFTER THE RESPONSE DATE |
| PRODUCT SERVICE CODE* |
| 6550 |
| CONTRACTING OFFICE ADDRESS |
| Department of Veteran Affairs |
Network Contracting Office 10 Battle Creek VA Medical Center 5500 Armstrong Rd.
Battle Creek MI 49037
POINT OF CONTACT*
Contracting Officer Jeffrey Rozema jeffrey.rozema@va.gov
ADDITIONAL INFORMATION
| AGENCY’S URL |
| https://www.va.gov |
| URL DESCRIPTION |
| Agency Homepage |
| AGENCY CONTACT’S EMAIL ADDRESS |
| jeffrey.rozema@va.gov |
| EMAIL DESCRIPTION |
| Contracting Officer |
DESCRIPTION
INTENT TO SOLE SOURCE
The Department of Veterans Affairs, VHA Regional Procurement Office Central, Network Contracting Office 10, intends to enter into a sole source procurement for Leica Bond-Max Reagents, Antibodies, Detection Kits, and Consumables for the John D. Dingell VA Medical Center, 4646 John R Street, Detroit, MI 48201. The Department of Veterans Affairs intends to award a sole source 5-year ordering period Indefinite Delivery Indefinite Quantity (IDIQ) contract to Leica Microsystems, Inc., 10 Parkway North, STE 300, Deerfield, IL 60015. The associated North American Industry Classification System (NAICS) Code is 334516 – Analytical Laboratory Instrument Manufacturing, and the Business Size Standard is 1,000 employees. The anticipated period of performance is September 1, 2024, through August 31, 2029.
This procurement is for reagents, antibodies, detection kits, and associated consumables for the Leica Bond-Max Immunochemistry Automated Histology Stainer currently owned and utilized by the Detroit VA laboratory. The detection kits for the Bond-Max can only be sourced from Leica. The Bond-Max does not allow detection kits from other vendors to be used. Similarly, the necessary antibody inventory for patient care and diagnosis is restricted to those obtained from Leica to forego the extensive validation necessary to use other vendor’s products. Leica supplied antibodies are validated for the Leica Bond-Max platform and therefore do not have to be independently validated as they are optimized and validated by Leica. It is the Government’s belief that Leica Microsystems, Inc. is the only vendor capable of providing all the Leica products needed for the Detroit VA and offering Leica quantity price discounts. The products needed include the following (Leica Catalog Number and Description):
Detection Kits
| DS9390 |
| Bond Polymer Refine Red Detection (100/test kit) |
Consumables
| AR9222 |
| Bond Dewax Solution |
| AR9961 |
| Bond TM Epitope Retrieval 1-1L |
| AR9640 |
| Bond TM Epitope Retrieval 2-1L |
| AR9590 |
| BondTM Wash Solution 10X Concentrate, 1L |
| S21.4611 |
| BOND Universal Covertiles (pack of 160) |
| AR9551 |
| Bond Enzyme Pretreatment Kit |
| S21.4604 |
| BOND Printer Ribbon & Labels Cxi (1Pack) |
| OPT9049 |
| Bond Titration Kit |
| S21.1971 |
| Bond Mixing Stations |
| OP79193 |
| Bond Open Containers 7ml |
| CS9100 |
| Bond Aspirating Probe Cleaning Kit |
In Situ Hybridization
| AR0222 |
| 15 mL Bond Anti-Fluorescein Ab |
| ISH5748-A |
| 7mL Kappa Probe - ASR |
| ISH5770-A |
| 7mL Lambda Probe - ASR |
| ISH5950-A |
| 7mL RNA Negative Control Probe - ASR |
| ISH5894-A |
| 7mL RNA Positive Control Probe - ASR |
Antibodies
| PA0094 |
| 7ml Cytokeratin (AE1/AE3) BOND RTU |
| PA0346 |
| 7ml Calretinin Bond RTU Primary |
| PA0117 |
| 7ml Bcl-2 Bond RTU Primary |
| PA0553 |
| 7ml CD3 Bond RTU Primary |
| PA0200 |
| 7ml CD20 (L26) Bond RTU Primary |
| PA0250 |
| 7ml CD31 Bond RTU Primary |
| PA0212 |
| 7ml CD34 Bond RTU Primary |
| PA0042 |
| 7ml CD45 Bond RTU Primary |
| PA0191 |
| 7ml CD56 Bond RTU Primary |
| PA0273 |
| 7ml CD68 Bond RTU Primary |
| PA0007 |
| 7ml CD117 (EP10) Bond RTU Primary |
| PA0088 |
| 7ml CD138 Bond RTU Primary |
| PA0375 |
| 7ml CDX2 (EP25) Bond RTU Primary |
| PA0848 |
| 7ml CEA (CD66e) (COL-1) Bond RTU Primary |
| PA0515 |
| 7ml ChromograninA (5H7) Bond RTU Primary |
| PA0942 |
| 7ml Cytokeratin 7 Bond RTU Primary |
| PA0022 |
| 7ml Cytokeratin 20 Bond RTU Primary |
| PA0032 |
| 7ml Desmin Bond RTU Primary |
| PA0801 |
| 7ML Hepatocyte Specific Antigen Hep-Par1 |
| PA0118 |
| 7ml Ki67 Bond RTU Primary |
| PA0233 |
| 7ml Melan A Bond RTU Primary |
| PA0258 |
| 7ml MuscSpecAct Bond RTU Prim |
| PA0163 |
| 7mL p40 (BC28) Bond RTU Primary |
| PA0006 |
| 7ml PAP Bond RTU Primary |
| PA0431 |
| 7ml PSA Bond RTU Primary |
| PA0031 |
| 7mL S-100 (EP32) BOND RTU Primary |
| PA0943 |
| 7ml SMA Bond RTU Primary |
| PA0299 |
| 7ml Synaptoph Bond RTU Primary |
| PA0364 |
| 7ml TTF-1 Bond RTU Primary |
| PA0640 |
| 7ml Vimentin Bond RTU Primary |
This notice satisfies the requirement at FAR 5.201(b)(1) to publicize the proposed contract action. This notice of intent is not a request for competitive proposals or quotes. Interested parties may identify their interest and capability to respond to the requirement. A determination not to compete this requirement, based upon responses to this notice, is solely within the discretion of the Government.
Interested persons may identify their interests and capability to respond to this requirement no later than 5:00 PM Eastern Time, Wednesday, July 31, 2024. Any response to this notice must show clear and convincing evidence that competition would be advantageous to the Government. Supporting evidence must be furnished in sufficient detail to demonstrate the ability to meet the subject requirement. This information shall be provided at no cost or obligation to the Government.
Interest/capability statements shall be submitted to Jeffrey Rozema, Contracting Officer, via e-mail at jeffrey.rozema@va.gov. Telephone inquiries will not be accepted.
| *= Required Field |
| Special Notice |
Special Notice
